CN102872299B - 一种治疗骨质疏松、骨质疏松骨折的药物组合物 - Google Patents
一种治疗骨质疏松、骨质疏松骨折的药物组合物 Download PDFInfo
- Publication number
- CN102872299B CN102872299B CN201210362272.7A CN201210362272A CN102872299B CN 102872299 B CN102872299 B CN 102872299B CN 201210362272 A CN201210362272 A CN 201210362272A CN 102872299 B CN102872299 B CN 102872299B
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- osteoporosis
- blood
- bone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 71
- 208000001132 Osteoporosis Diseases 0.000 title claims abstract description 29
- 208000001164 Osteoporotic Fractures Diseases 0.000 title claims abstract description 13
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title description 15
- 238000011282 treatment Methods 0.000 claims abstract description 40
- 241000903946 Clematidis Species 0.000 claims abstract description 4
- 239000004863 Frankincense Substances 0.000 claims abstract description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims description 11
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 241000717739 Boswellia sacra Species 0.000 claims description 3
- 241001550206 Colla Species 0.000 claims description 3
- 241000209020 Cornus Species 0.000 claims description 3
- 241001489978 Eupolyphaga Species 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 241001057584 Myrrha Species 0.000 claims description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 43
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract description 3
- 229910052802 copper Inorganic materials 0.000 abstract description 3
- 239000010949 copper Substances 0.000 abstract description 3
- 241001608711 Melo Species 0.000 abstract description 2
- 210000000582 semen Anatomy 0.000 abstract description 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000132011 Atractylodes lancea Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000610743 Psathyrotes ramosissima Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 210000003056 antler Anatomy 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 239000003292 glue Substances 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 64
- 210000004369 blood Anatomy 0.000 description 63
- 210000000988 bone and bone Anatomy 0.000 description 51
- 210000003734 kidney Anatomy 0.000 description 50
- 210000004185 liver Anatomy 0.000 description 39
- 208000002193 Pain Diseases 0.000 description 35
- 230000036407 pain Effects 0.000 description 35
- 210000003205 muscle Anatomy 0.000 description 30
- 230000001737 promoting effect Effects 0.000 description 29
- 230000007812 deficiency Effects 0.000 description 19
- 210000002435 tendon Anatomy 0.000 description 19
- 230000017531 blood circulation Effects 0.000 description 18
- 208000010392 Bone Fractures Diseases 0.000 description 17
- 210000001624 hip Anatomy 0.000 description 17
- 238000005728 strengthening Methods 0.000 description 16
- 206010017076 Fracture Diseases 0.000 description 15
- 210000000952 spleen Anatomy 0.000 description 15
- 235000009508 confectionery Nutrition 0.000 description 13
- 230000008961 swelling Effects 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 13
- 208000014674 injury Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 208000006820 Arthralgia Diseases 0.000 description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 9
- 239000011575 calcium Substances 0.000 description 9
- 229910052791 calcium Inorganic materials 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 8
- 239000010839 body fluid Substances 0.000 description 8
- 208000008035 Back Pain Diseases 0.000 description 7
- 208000008930 Low Back Pain Diseases 0.000 description 7
- 208000025747 Rheumatic disease Diseases 0.000 description 7
- 206010003549 asthenia Diseases 0.000 description 7
- 230000008468 bone growth Effects 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 230000000552 rheumatic effect Effects 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 210000003414 extremity Anatomy 0.000 description 6
- 210000003127 knee Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000008736 traumatic injury Effects 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 210000001185 bone marrow Anatomy 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 230000002607 hemopoietic effect Effects 0.000 description 5
- 210000000629 knee joint Anatomy 0.000 description 5
- 231100000862 numbness Toxicity 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 208000036119 Frailty Diseases 0.000 description 4
- 206010019468 Hemiplegia Diseases 0.000 description 4
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000037118 bone strength Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000021595 spermatogenesis Effects 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000009916 joint effect Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000001009 osteoporotic effect Effects 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000037182 bone density Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 210000004409 osteocyte Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000027502 Ankle fracture Diseases 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010214 Compression fracture Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000008924 Femoral Fractures Diseases 0.000 description 1
- 208000007875 Femur Head Necrosis Diseases 0.000 description 1
- 206010017081 Fracture delayed union Diseases 0.000 description 1
- 206010018985 Haemorrhage intracranial Diseases 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- 206010020100 Hip fracture Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 201000002980 Hyperparathyroidism Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000008574 Intracranial Hemorrhages Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000030136 Marchiafava-Bignami Disease Diseases 0.000 description 1
- 208000029725 Metabolic bone disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 101710167839 Morphogenetic protein Proteins 0.000 description 1
- 208000010718 Multiple Organ Failure Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000006193 Pulmonary infarction Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 244000237957 Schisandra propinqua Species 0.000 description 1
- 206010039984 Senile osteoporosis Diseases 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 208000002103 Shoulder Fractures Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043949 Tongue discolouration Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- -1 bitter in the mouth Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 230000018678 bone mineralization Effects 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 210000000459 calcaneus Anatomy 0.000 description 1
- MWKXCSMICWVRGW-UHFFFAOYSA-N calcium;phosphane Chemical compound P.[Ca] MWKXCSMICWVRGW-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229940084954 dexamethasone 1 mg Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000002984 haematinic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000002758 humerus Anatomy 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 208000027753 pain disease Diseases 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000007575 pulmonary infarction Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 206010039722 scoliosis Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000920 spermatogeneic effect Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
治愈 | 显效 | 有效 | 无效 | 总有效率 | |
治疗组 | 33 | 38 | 29 | 12 | 90% |
对照组 | 15 | 33 | 30 | 37 | 68% |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210362272.7A CN102872299B (zh) | 2012-09-26 | 2012-09-26 | 一种治疗骨质疏松、骨质疏松骨折的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210362272.7A CN102872299B (zh) | 2012-09-26 | 2012-09-26 | 一种治疗骨质疏松、骨质疏松骨折的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102872299A CN102872299A (zh) | 2013-01-16 |
CN102872299B true CN102872299B (zh) | 2014-04-30 |
Family
ID=47473969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210362272.7A Expired - Fee Related CN102872299B (zh) | 2012-09-26 | 2012-09-26 | 一种治疗骨质疏松、骨质疏松骨折的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102872299B (zh) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102988688B (zh) * | 2012-11-27 | 2014-11-12 | 高金菊 | 一种促进骨伤愈合的药酒的制备方法 |
CN103263572B (zh) * | 2013-05-31 | 2014-07-02 | 李伟丽 | 一种治疗骨质疏松症的中药组合物及其制备方法 |
CN103392986B (zh) * | 2013-08-13 | 2014-09-03 | 青岛福加德面粉有限公司 | 一种老年保健小麦面粉及其制备方法 |
CN103461805B (zh) * | 2013-08-18 | 2014-07-16 | 青岛福加德面粉有限公司 | 一种可用于骨质疏松病人食用的面粉 |
CN103495011B (zh) * | 2013-09-24 | 2014-09-03 | 宁波保税区欣诺生物技术有限公司 | 一种治疗骨质疏松的中药片剂的制备方法 |
CN103599327A (zh) * | 2013-11-11 | 2014-02-26 | 漯河医学高等专科学校 | 自拟壮骨实疏饮防治原发性骨质疏松症方法 |
CN103735830B (zh) * | 2014-01-26 | 2016-05-25 | 陈新 | 一种治疗骨质疏松的中药组合物 |
CN103784769A (zh) * | 2014-03-07 | 2014-05-14 | 王奎林 | 一种治疗骨科疾病的中药制剂 |
CN103893390A (zh) * | 2014-04-15 | 2014-07-02 | 孟小斐 | 一种预防大肠癌化疗后骨质疏松的中药及其制备方法 |
CN104000929B (zh) * | 2014-05-12 | 2016-09-14 | 永州职业技术学院 | 治疗骨质疏松、骨质增生的药物及其制备方法 |
CN104042837B (zh) * | 2014-06-19 | 2017-10-10 | 马伯艳 | 一种用于骨及骨关节退行性病变的药物组合物 |
CN104013769A (zh) * | 2014-06-21 | 2014-09-03 | 徐显廷 | 一种治疗骨质疏松的中药口服液 |
CN104138521A (zh) * | 2014-08-05 | 2014-11-12 | 苏义燕 | 一种治疗阴阳两虚证型绝经妇女骨质疏松的中药 |
SG10201405843VA (en) * | 2014-09-18 | 2016-04-28 | Root King Pte Ltd | A composition suitable for vegetarians providing calcium supplementation as well as gout prevention and treatment and the method of preparation thereof |
CN104435531A (zh) * | 2014-11-06 | 2015-03-25 | 成都果睿医药科技有限公司 | 治疗骨质疏松的药物组合物 |
CN104435311A (zh) * | 2014-11-12 | 2015-03-25 | 青岛恒波仪器有限公司 | 一种补肾壮骨的菟丝子口服液及其制备方法 |
CN104337935B (zh) * | 2014-11-17 | 2016-06-08 | 吉林大学 | 一种治疗骨质疏松的银杏叶复方中药制剂及制备方法 |
CN104548018A (zh) * | 2014-12-31 | 2015-04-29 | 东莞市智健医疗科技有限公司 | 一种治疗骨折的中药组合物及其新用途 |
CN104547358A (zh) * | 2015-02-11 | 2015-04-29 | 陈红 | 一种治疗脾肾阳虚型绝经后骨质疏松症的中药制剂 |
CN104740475A (zh) * | 2015-03-14 | 2015-07-01 | 吴鹏 | 一种预防骨质疏松性椎体骨折的中药制剂 |
CN104688932A (zh) * | 2015-04-08 | 2015-06-10 | 房经武 | 一种用于绝经后骨质疏松症的中药制剂及制备方法 |
CN105168614A (zh) * | 2015-09-08 | 2015-12-23 | 张洲玲 | 一种补肾健骨的中药及其制备方法 |
KR101646923B1 (ko) * | 2016-01-28 | 2016-08-23 | 류홍선 | 한약재 추출물을 포함하는 동물사료 조성물 |
CN105616704A (zh) * | 2016-02-29 | 2016-06-01 | 南阳理工学院 | 一种骨质疏松骨折骨质愈合的中药制剂 |
CN105748830A (zh) * | 2016-04-26 | 2016-07-13 | 郑州市中医院 | 一种壮骨汤及其制备方法 |
CN110051771A (zh) * | 2019-06-14 | 2019-07-26 | 陕西中医药大学 | 一种治疗骨质疏松的中药片剂及其制备方法 |
CN114949079B (zh) * | 2022-08-02 | 2022-10-25 | 吉林瑞隆药业有限责任公司 | 一种用于骨质疏松的药物组合物及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1197601C (zh) * | 2003-01-27 | 2005-04-20 | 鲁南制药股份有限公司 | 一种治疗骨质疏松的药物及其制备方法 |
CN102526405B (zh) * | 2012-02-20 | 2013-08-21 | 崔新明 | 一种加快骨折愈合的中药组合物 |
-
2012
- 2012-09-26 CN CN201210362272.7A patent/CN102872299B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102872299A (zh) | 2013-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102872299B (zh) | 一种治疗骨质疏松、骨质疏松骨折的药物组合物 | |
CN101366919B (zh) | 一种治疗风湿类疾病的中药药膏 | |
CN100423761C (zh) | 一种治疗骨折、跌打损伤的中药制剂 | |
CN103349753B (zh) | 一种治疗肾虚的中药组合物 | |
CN101428115B (zh) | 一种妇女滋阴、补血的药酒 | |
CN104353019A (zh) | 舒经调脏的中药热敷袋及其制备方法 | |
CN101239151B (zh) | 一种防治心脑血管疾病的中药及制备方法 | |
CN102698093B (zh) | 一种治疗肝肾阴虚型高血压的中药组合物及其制备方法 | |
CN101181488A (zh) | 一种内服治疗骨质疏松的中药组合物 | |
CN103599404A (zh) | 一种治疗颈椎病的中药汤剂 | |
CN104721704A (zh) | 一种治疗月经不调的中药 | |
CN103212044B (zh) | 一种治疗心血管疾病的中药组合物 | |
CN102600414B (zh) | 一种治疗颈椎病的中药组合物 | |
CN102218119B (zh) | 治疗风湿和股骨头坏死及月子病的中草药 | |
CN106267013A (zh) | 一种治疗股骨头坏死的丸药 | |
CN104352946A (zh) | 用于骨质疏松的中成药物制剂 | |
CN104398664A (zh) | 一种治疗排卵障碍性不孕症的壮药组合物 | |
CN102973849B (zh) | 妇科宁心活血调经中药制剂 | |
CN102512543A (zh) | 一种治疗类风湿的中药组合物 | |
CN105213793A (zh) | 主治骨质疏松的中药组合物及制法 | |
CN105343862A (zh) | 一种用于软组织损伤、骨折的药物组合物 | |
CN105616704A (zh) | 一种骨质疏松骨折骨质愈合的中药制剂 | |
CN104815312A (zh) | 一种用于腰椎椎管狭窄术后护理的中药制剂及制备方法 | |
CN104826095A (zh) | 一种软骨素联产蛋白粉及其生产方法和应用 | |
CN104706983A (zh) | 一种治疗颈椎病的中药汤剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Cai Zhen Inventor after: Guan Yifang Inventor after: Wu Shuxi Inventor before: Wu Shuxi |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WU SHUXI TO: CAI ZHEN GUAN YIFANG WU SHUXI |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NANTONG KANGWEIER BIOCHEMICAL ENGINEERING CO., LTD Free format text: FORMER OWNER: WU SHUXI Effective date: 20141230 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 276003 LINYI, SHANDONG PROVINCE TO: 226500 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141230 Address after: 226500, Jiangsu City, Rugao Province, such as Town Star Road 8-6 Patentee after: NANTONG KWESW BIOCHEMICAL CO.,LTD. Address before: 276003 200 meters east Party school, north section of Yimeng Road, Shandong, Linyi City People's Hospital, North Medical District, Linyi Patentee before: Wu Shuxi |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140430 |
|
CF01 | Termination of patent right due to non-payment of annual fee |